Faster drug screening achieved with 3D imaging system from Hamamatsu
(l-r): Guillaume Desmartin, Bruno Emica, Ghent Kossayer, Lucie Lecouflet, Romane Florent, Jean-Marc D’Angelo, Jordane Divoux, Louis-Bastien Weiswald, Laurent Poulain and Jérémie Le Goff (Image: Hamamatsu Photonics)
Organoid analysis company Orgapred built a personalised oncology research workflow using Hamamatsu’s Cytoqube platform
Register for FREE to keep reading
Join 10,000+ vision professionals driving innovation in automation, AI and imaging with:
- Expert insights on vision, robotics, AI & embedded tech
- Newsletters and features covering the full imaging landscape
- Visionaries series: leadership strategies in imaging
- Free panels on smart manufacturing & autonomy
- White Papers & updates for smarter integration
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
